Who Just RaisedWoodbury, MN · Health Care · Form D filed Aug 26, 2026
ProEncia Biotechnology Inc. raised $1.5M
ProEncia Biotechnology Inc. is a biotechnology company based in Woodbury, Minnesota. In a Form D filed with the SEC on August 26, 2026, it reported raising $1,510,000 from 14 investors as part of an offering of up to $2,000,000. The first sale in the offering took place on October 4, 2024.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
- Still raising. $490K of the $2M offering was still unsold at filing.
$1.5M raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 26, 2026 | $1.5M | $2M | 14 |
Lead score
33 out of 100
first raise ever still raising budget to spend
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $1,510,000
- Offering size
- $2,000,000
- Investors so far
- 14
- Minimum investment
- $25,000
- First sale
- October 4, 2024
- Securities offered
- Equity, Debt
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Woodbury, Minnesota
- Incorporated
- Minnesota, 2022
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $1,510,000 | $2,000,000 | 14 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 24, 2026 · Health Care funding in Minnesota · August 2026 funding report
Similar raises
Surgicare of Minneapolis, Ltd.
St. Louis Park, MN · filed Oct 87th Form D since 2011
Vireo Growth Inc.
Minneapolis, MN · filed Oct 7
Vireo Growth, Inc.'s mission is to provide safe access, quality and value to its customers while supporting its communities through active participation and restorative justice programs. The Company…
17th Form D since 2019
Piraeus Medical, Inc.
Rochester, MN · filed Oct 7
11th Form D since 2022Still raising
Pelvital USA, Inc.
Eagan, MN · filed Oct 58th Form D since 2020Still raising
Evia Bio, Inc.
Minneapolis, MN · filed Sep 28
Evia Bio’s cryopreservation technology enables the entire Cell Therapy supply chain with high product yield, efficacy, and safety. You don’t have to settle for less.
First Form D
EyeMacular Regeneration, Inc.
St. Paul, MN · filed Sep 252nd Form D since 2024Still raising
InSitu Biologics, Inc.
Oakdale, MN · filed Aug 10
InSitu Biologics is advancing localized sustained-release drug delivery, starting with INSB200™, a peripheral nerve block for extended post-surgical pain relief.
6th Form D since 2017Still raising
Pelva Health Corp
Edina, MN · filed Aug 72nd Form D since 2024Still raising